9/14/2026
Psyence BioMed launches US ibogaine subsidiary
New Texas-based entity to spearhead ibogaine research and development in the US.
Topic archive
neuroplastogen
2 stories
9/14/2026
Psyence BioMed expands U.S. ibogaine research with Texas unit
New subsidiary aims to centralize ibogaine supply and regulatory efforts in the U.S.